What Researchers Did
Researchers conducted a review to explore the potential role of hyperbaric oxygen therapy (HBOT) in the resuscitative management of acutely ill or severely injured patients with severe anemia.
What They Found
They found that hyperbaric oxygen therapy (HBOT) can safely allow plasma to meet oxygen delivery requirements, potentially reducing blood transfusion needs in special instances. HBOT can efficiently provide superior oxygen diffusion in tissue, resupply adenosine triphosphate for cellular function, and ameliorate reperfusion injury, with a very low complication rate.
What This Means for Canadian Patients
For Canadian patients experiencing severe anemia due to acute illness or injury, hyperbaric oxygen therapy could potentially serve as a temporary measure to maintain oxygen delivery and reduce the immediate need for blood transfusions. This approach might offer a bridge to definitive treatment, especially in situations where blood products are scarce or contraindicated, by supporting vital cellular functions.
Canadian Relevance
This review does not have a direct Canadian connection.
Study Limitations
As a review, this study synthesizes existing literature without presenting new primary data or clinical trial results, which limits its ability to provide definitive clinical recommendations.